The Peter Attia Drive

The Peter Attia Drive

#75 - David Light: Zantac recall due to cancer concerns – what you need to know

Oct 14, 2019 · 01:37:30

Listen to Episode

✨ AI Summary

David Light explains the Zantac recall due to cancer concerns.
Details the role of Valisure in identifying ranitidine risks.
Discusses the evidence and the FDA's reaction to the recall.

More from The Peter Attia Drive

#385 - AMA #82: Applying the tools of longevity in the real world: disease prevention, DEXA scans, artificial sweeteners, injury recovery, stability training, habit formation, protein intake and mTOR activation, and more

Mar 23, 2026 · 18:52

#384 - Special episode — Obicetrapib: The CETP inhibitor with cardiovascular benefits and potential Alzheimer's prevention

Mar 16, 2026 · 52:40

#381 ‒ Alzheimer's disease in women: how hormonal transitions impact the female brain, the role of HRT, genetics, and lifestyle on risk, and emerging diagnostics and therapies | Lisa Mosconi, Ph.D.

Jan 26, 2026 · 02:06:34

#380 ‒ The seed oil debate: are they uniquely harmful relative to other dietary fats? | Layne Norton, Ph.D.

Jan 19, 2026 · 02:07:42

View all episodes →